The once dominant ecigarette company faces more legal challenges and FDA scrutiny after a probe into whether it deceptively marketed to children and teens. Wired
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with that.OkMore infromation